Lonza’s innovative continuous flow technology and mini-monoplant approach are transforming early-phase drug development. How ...

The two companies have been working together since 2017, and, in 2021, they agreed to collaborate on NM26, a bispecific ...

An average drug candidate takes 10 to 15 years to progress through the development cycle. For every 5,000 compounds that ...

The path from a scientist’s initial idea to a new medicine that can save lives is a complex and often lengthy process. It ...

23andMe's big push into drug development, announced with great fanfare almost a decade ago, has ended with a whimper and ...

CN Bio, a leading provider of Organ-on-a-chip Systems and solutions that accelerate drug discovery and development workflows, today announced the launch of its PhysioMimix® Bioavailability assay kit: ...

Evidence has been growing to suggest that tetrahydrocannabinol (THC), the main psychoactive ingredient in cannabis, poses risks to the developing fetus by impacting brain development. Now a new ...

The rise of antibody therapeutics is transforming drug discovery, providing highly specific treatments for complex diseases ...

A new drug strategy that regulates the tumor immune ... the kit enhances lead optimization and preclinical testing pipelines, providing an all-in-one solution to generate predictive insights ...

Preclinical proof-of-concept data supports the potential of CD3 Switch-DARPin platform to activate and boost T cells in the presence of tumor ...